Global Nonalcoholic Fatty Liver Disease Market Professional Survey Report 2016
- QYR684818
- 112 Pages
- August 2016
- Pharmaceuticals
Production, means the output of Nonalcoholic Fatty Liver Disease
Revenue, means the sales value of Nonalcoholic Fatty Liver Disease
This report studies Nonalcoholic Fatty Liver Disease in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021.
This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Conatus Pharmaceuticals
Daewoong Pharmaceutical
Galmed International
Kyorin Pharmaceutical
Metabolic Solutions Development
Novartis AG
Phenex Pharmaceuticals
Raptor Pharmaceuticals
TCM Biotech International
Tobira Therapeutics
By types, the market can be split into
Type I
Type II
Type III
By Application, the market can be split into
Application 1
Application 2
Application 3
By Regions, this report covers (we can add the regions/countries as you want)
North America
China
Europe
Southeast Asia
Japan
India
Global Nonalcoholic Fatty Liver Disease Market Professional Survey Report 2016
1 Industry Overview of Nonalcoholic Fatty Liver Disease
1.1 Definition and Specifications of Nonalcoholic Fatty Liver Disease
1.1.1 Definition of Nonalcoholic Fatty Liver Disease
1.1.2 Specifications of Nonalcoholic Fatty Liver Disease
1.2 Classification of Nonalcoholic Fatty Liver Disease
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Applications of Nonalcoholic Fatty Liver Disease
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
2 Manufacturing Cost Structure Analysis of Nonalcoholic Fatty Liver Disease
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Nonalcoholic Fatty Liver Disease
2.3 Manufacturing Process Analysis of Nonalcoholic Fatty Liver Disease
2.4 Industry Chain Structure of Nonalcoholic Fatty Liver Disease
3 Technical Data and Manufacturing Plants Analysis of Nonalcoholic Fatty Liver Disease
3.1 Capacity and Commercial Production Date of Global Nonalcoholic Fatty Liver Disease Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Nonalcoholic Fatty Liver Disease Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Nonalcoholic Fatty Liver Disease Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Nonalcoholic Fatty Liver Disease Major Manufacturers in 2015
4 Global Nonalcoholic Fatty Liver Disease Overall Market Overview
4.1 2011-2016E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2011-2016E Global Nonalcoholic Fatty Liver Disease Capacity and Growth Rate Analysis
4.2.2 2015 Nonalcoholic Fatty Liver Disease Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2011-2016E Global Nonalcoholic Fatty Liver Disease Sales and Growth Rate Analysis
4.3.2 2015 Nonalcoholic Fatty Liver Disease Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2011-2016E Global Nonalcoholic Fatty Liver Disease Sales Price
4.4.2 2015 Nonalcoholic Fatty Liver Disease Sales Price Analysis (Company Segment)
5 Nonalcoholic Fatty Liver Disease Regional Market Analysis
5.1 North America Nonalcoholic Fatty Liver Disease Market Analysis
5.1.1 North America Nonalcoholic Fatty Liver Disease Market Overview
5.1.2 North America 2011-2016E Nonalcoholic Fatty Liver Disease Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2011-2016E Nonalcoholic Fatty Liver Disease Sales Price Analysis
5.1.4 North America 2015 Nonalcoholic Fatty Liver Disease Market Share Analysis
5.2 China Nonalcoholic Fatty Liver Disease Market Analysis
5.2.1 China Nonalcoholic Fatty Liver Disease Market Overview
5.2.2 China 2011-2016E Nonalcoholic Fatty Liver Disease Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2011-2016E Nonalcoholic Fatty Liver Disease Sales Price Analysis
5.2.4 China 2015 Nonalcoholic Fatty Liver Disease Market Share Analysis
5.3 Europe Nonalcoholic Fatty Liver Disease Market Analysis
5.3.1 Europe Nonalcoholic Fatty Liver Disease Market Overview
5.3.2 Europe 2011-2016E Nonalcoholic Fatty Liver Disease Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2011-2016E Nonalcoholic Fatty Liver Disease Sales Price Analysis
5.3.4 Europe 2015 Nonalcoholic Fatty Liver Disease Market Share Analysis
5.4 Southeast Asia Nonalcoholic Fatty Liver Disease Market Analysis
5.4.1 Southeast Asia Nonalcoholic Fatty Liver Disease Market Overview
5.4.2 Southeast Asia 2011-2016E Nonalcoholic Fatty Liver Disease Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2011-2016E Nonalcoholic Fatty Liver Disease Sales Price Analysis
5.4.4 Southeast Asia 2015 Nonalcoholic Fatty Liver Disease Market Share Analysis
5.5 Japan Nonalcoholic Fatty Liver Disease Market Analysis
5.5.1 Japan Nonalcoholic Fatty Liver Disease Market Overview
5.5.2 Japan 2011-2016E Nonalcoholic Fatty Liver Disease Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2011-2016E Nonalcoholic Fatty Liver Disease Sales Price Analysis
5.5.4 Japan 2015 Nonalcoholic Fatty Liver Disease Market Share Analysis
5.6 India Nonalcoholic Fatty Liver Disease Market Analysis
5.6.1 India Nonalcoholic Fatty Liver Disease Market Overview
5.6.2 India 2011-2016E Nonalcoholic Fatty Liver Disease Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2011-2016E Nonalcoholic Fatty Liver Disease Sales Price Analysis
5.6.4 India 2015 Nonalcoholic Fatty Liver Disease Market Share Analysis
6 Global 2011-2016E Nonalcoholic Fatty Liver Disease Segment Market Analysis (by Type)
6.1 Global 2011-2016E Nonalcoholic Fatty Liver Disease Sales by Type
6.2 Different Types of Nonalcoholic Fatty Liver Disease Product Interview Price Analysis
6.3 Different Types of Nonalcoholic Fatty Liver Disease Product Driving Factors Analysis
6.3.1 Type I Nonalcoholic Fatty Liver Disease Growth Driving Factor Analysis
6.3.2 Type II Nonalcoholic Fatty Liver Disease Growth Driving Factor Analysis
6.3.3 Type III Nonalcoholic Fatty Liver Disease Growth Driving Factor Analysis
7 Global 2011-2016E Nonalcoholic Fatty Liver Disease Segment Market Analysis (by Application)
7.1 Global 2011-2016E Nonalcoholic Fatty Liver Disease Consumption by Application
7.2 Different Application of Nonalcoholic Fatty Liver Disease Product Interview Price Analysis
7.3 Different Application of Nonalcoholic Fatty Liver Disease Product Driving Factors Analysis
7.3.1 Application 1 Nonalcoholic Fatty Liver Disease Growth Driving Factor Analysis
7.3.2 Application 2 Nonalcoholic Fatty Liver Disease Growth Driving Factor Analysis
7.3.3 Application 3 Nonalcoholic Fatty Liver Disease Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Nonalcoholic Fatty Liver Disease
8.1 Conatus Pharmaceuticals
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Type I
8.1.2.2 Type II
8.1.2.3 Type III
8.1.3 Conatus Pharmaceuticals 2015 Nonalcoholic Fatty Liver Disease Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Conatus Pharmaceuticals 2015 Nonalcoholic Fatty Liver Disease Business Region Distribution Analysis
8.2 Daewoong Pharmaceutical
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Type I
8.2.2.2 Type II
8.2.2.3 Type III
8.2.3 Daewoong Pharmaceutical 2015 Nonalcoholic Fatty Liver Disease Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Daewoong Pharmaceutical 2015 Nonalcoholic Fatty Liver Disease Business Region Distribution Analysis
8.3 Galmed International
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Type I
8.3.2.2 Type II
8.3.2.3 Type III
8.3.3 Galmed International 2015 Nonalcoholic Fatty Liver Disease Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Galmed International 2015 Nonalcoholic Fatty Liver Disease Business Region Distribution Analysis
8.4 Kyorin Pharmaceutical
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Type I
8.4.2.2 Type II
8.4.2.3 Type III
8.4.3 Kyorin Pharmaceutical 2015 Nonalcoholic Fatty Liver Disease Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Kyorin Pharmaceutical 2015 Nonalcoholic Fatty Liver Disease Business Region Distribution Analysis
8.5 Metabolic Solutions Development
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Type I
8.5.2.2 Type II
8.5.2.3 Type III
8.5.3 Metabolic Solutions Development 2015 Nonalcoholic Fatty Liver Disease Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Metabolic Solutions Development 2015 Nonalcoholic Fatty Liver Disease Business Region Distribution Analysis
8.6 Novartis AG
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Type I
8.6.2.2 Type II
8.6.2.3 Type III
8.6.3 Novartis AG 2015 Nonalcoholic Fatty Liver Disease Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Novartis AG 2015 Nonalcoholic Fatty Liver Disease Business Region Distribution Analysis
8.7 Phenex Pharmaceuticals
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Type I
8.7.2.2 Type II
8.7.2.3 Type III
8.7.3 Phenex Pharmaceuticals 2015 Nonalcoholic Fatty Liver Disease Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Phenex Pharmaceuticals 2015 Nonalcoholic Fatty Liver Disease Business Region Distribution Analysis
8.8 Raptor Pharmaceuticals
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Type I
8.8.2.2 Type II
8.8.2.3 Type III
8.8.3 Raptor Pharmaceuticals 2015 Nonalcoholic Fatty Liver Disease Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Raptor Pharmaceuticals 2015 Nonalcoholic Fatty Liver Disease Business Region Distribution Analysis
8.9 TCM Biotech International
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Type I
8.9.2.2 Type II
8.9.2.3 Type III
8.9.3 TCM Biotech International 2015 Nonalcoholic Fatty Liver Disease Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 TCM Biotech International 2015 Nonalcoholic Fatty Liver Disease Business Region Distribution Analysis
8.10 Tobira Therapeutics
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Type I
8.10.2.2 Type II
8.10.2.3 Type III
8.10.3 Tobira Therapeutics 2015 Nonalcoholic Fatty Liver Disease Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Tobira Therapeutics 2015 Nonalcoholic Fatty Liver Disease Business Region Distribution Analysis
9 Development Trend of Analysis of Nonalcoholic Fatty Liver Disease Market
9.1 Global Nonalcoholic Fatty Liver Disease Market Trend Analysis
9.1.1 Global 2016-2021 Nonalcoholic Fatty Liver Disease Market Size (Volume and Value) Forecast
9.1.2 Global 2016-2021 Nonalcoholic Fatty Liver Disease Sales Price Forecast
9.2 Nonalcoholic Fatty Liver Disease Regional Market Trend
9.2.1 North America 2016-2021 Nonalcoholic Fatty Liver Disease Consumption Forecast
9.2.2 China 2016-2021 Nonalcoholic Fatty Liver Disease Consumption Forecast
9.2.3 Europe 2016-2021 Nonalcoholic Fatty Liver Disease Consumption Forecast
9.2.4 Southeast Asia 2016-2021 Nonalcoholic Fatty Liver Disease Consumption Forecast
9.2.5 Japan 2016-2021 Nonalcoholic Fatty Liver Disease Consumption Forecast
9.2.6 India 2016-2021 Nonalcoholic Fatty Liver Disease Consumption Forecast
9.3 Nonalcoholic Fatty Liver Disease Market Trend (Product Type)
9.4 Nonalcoholic Fatty Liver Disease Market Trend (Application)
10 Nonalcoholic Fatty Liver Disease Marketing Type Analysis
10.1 Nonalcoholic Fatty Liver Disease Regional Marketing Type Analysis
10.2 Nonalcoholic Fatty Liver Disease International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Nonalcoholic Fatty Liver Disease by Regions
10.4 Nonalcoholic Fatty Liver Disease Supply Chain Analysis
11 Consumers Analysis of Nonalcoholic Fatty Liver Disease
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
…
12 Conclusion of the Global Nonalcoholic Fatty Liver Disease Market Professional Survey Report 2016
Author List
Table Part of Interviewees Record List
Disclosure Section
Research Methodology
Data Source
China Disclaimer
Figure Picture of Nonalcoholic Fatty Liver Disease
Table Product Specifications of Nonalcoholic Fatty Liver Disease
Table Classification of Nonalcoholic Fatty Liver Disease
Figure Global Production Market Share of Nonalcoholic Fatty Liver Disease by Type in 2015
Table Applications of Nonalcoholic Fatty Liver Disease
Figure Global Consumption Volume Market Share of Nonalcoholic Fatty Liver Disease by Application in 2015
Figure Market Share of Nonalcoholic Fatty Liver Disease by Regions
Figure North America Nonalcoholic Fatty Liver Disease Market Size (2011-2021)
Figure China Nonalcoholic Fatty Liver Disease Market Size (2011-2021)
Figure Europe Nonalcoholic Fatty Liver Disease Market Size (2011-2021)
Figure Southeast Asia Nonalcoholic Fatty Liver Disease Market Size (2011-2021)
Figure Japan Nonalcoholic Fatty Liver Disease Market Size (2011-2021)
Figure India Nonalcoholic Fatty Liver Disease Market Size (2011-2021)
Table Nonalcoholic Fatty Liver Disease Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Nonalcoholic Fatty Liver Disease in 2015
Figure Manufacturing Process Analysis of Nonalcoholic Fatty Liver Disease
Figure Industry Chain Structure of Nonalcoholic Fatty Liver Disease
Table Capacity (K Units) and Commercial Production Date of Global Nonalcoholic Fatty Liver Disease Major Manufacturers in 2015
Table Manufacturing Plants Distribution of Global Nonalcoholic Fatty Liver Disease Major Manufacturers in 2015
Table R&D Status and Technology Source of Global Nonalcoholic Fatty Liver Disease Major Manufacturers in 2015
Table Raw Materials Sources Analysis of Global Nonalcoholic Fatty Liver Disease Major Manufacturers in 2015
Table Global Capacity (K Units), Sales (K Units), Price (USD/Unit), Cost (USD/Unit), Sales Revenue (M USD) and Gross Margin of Nonalcoholic Fatty Liver Disease 2011-2016
Figure Global 2011-2016E Nonalcoholic Fatty Liver Disease Market Size (Volume) and Growth Rate
Figure Global 2011-2016E Nonalcoholic Fatty Liver Disease Market Size (Value) and Growth Rate
Table 2011-2016E Global Nonalcoholic Fatty Liver Disease Capacity and Growth Rate
Table 2015 Global Nonalcoholic Fatty Liver Disease Capacity List (Company Segment)
Table 2011-2016E Global Nonalcoholic Fatty Liver Disease Sales and Growth Rate
Table 2015 Global Nonalcoholic Fatty Liver Disease Sales List (Company Segment)
Table 2011-2016E Global Nonalcoholic Fatty Liver Disease Sales Price
Table 2015 Global Nonalcoholic Fatty Liver Disease Sales Price List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption of Nonalcoholic Fatty Liver Disease 2011-2016 (K Units)
Figure North America 2011-2016E Nonalcoholic Fatty Liver Disease Sales Price (USD/Unit)
Figure North America 2015 Nonalcoholic Fatty Liver Disease Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption of Nonalcoholic Fatty Liver Disease 2011-2016 (K Units)
Figure China 2011-2016E Nonalcoholic Fatty Liver Disease Sales Price (USD/Unit)
Figure China 2015 Nonalcoholic Fatty Liver Disease Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption of Nonalcoholic Fatty Liver Disease 2011-2016 (K Units)
Figure Europe 2011-2016E Nonalcoholic Fatty Liver Disease Sales Price (USD/Unit)
Figure Europe 2015 Nonalcoholic Fatty Liver Disease Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption of Nonalcoholic Fatty Liver Disease 2011-2016 (K Units)
Figure Southeast Asia 2011-2016E Nonalcoholic Fatty Liver Disease Sales Price (USD/Unit)
Figure Southeast Asia 2015 Nonalcoholic Fatty Liver Disease Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption of Nonalcoholic Fatty Liver Disease 2011-2016 (K Units)
Figure Japan 2011-2016E Nonalcoholic Fatty Liver Disease Sales Price (USD/Unit)
Figure Japan 2015 Nonalcoholic Fatty Liver Disease Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption of Nonalcoholic Fatty Liver Disease 2011-2016 (K Units)
Figure India 2011-2016E Nonalcoholic Fatty Liver Disease Sales Price (USD/Unit)
Figure India 2015 Nonalcoholic Fatty Liver Disease Sales Market Share
Table Global 2011-2016E Nonalcoholic Fatty Liver Disease Sales by Type
Table Different Types Nonalcoholic Fatty Liver Disease Product Interview Price
Table Global 2011-2016E Nonalcoholic Fatty Liver Disease Sales by Application
Table Different Application Nonalcoholic Fatty Liver Disease Product Interview Price
Table Conatus Pharmaceuticals Information List
Table Type I Nonalcoholic Fatty Liver Disease Overview
Table Type II Nonalcoholic Fatty Liver Disease Overview
Table Type III Nonalcoholic Fatty Liver Disease Overview
Table 2015 Conatus Pharmaceuticals Nonalcoholic Fatty Liver Disease Revenue, Sales, Ex-factory Price
Figure 2015 Conatus Pharmaceuticals 2015 Nonalcoholic Fatty Liver Disease Business Region Distribution
Table Daewoong Pharmaceutical Information List
Table Type I Nonalcoholic Fatty Liver Disease Overview
Table Type II Nonalcoholic Fatty Liver Disease Overview
Table Type III Nonalcoholic Fatty Liver Disease Overview
Table 2015 Daewoong Pharmaceutical Nonalcoholic Fatty Liver Disease Revenue, Sales, Ex-factory Price
Figure 2015 Daewoong Pharmaceutical 2015 Nonalcoholic Fatty Liver Disease Business Region Distribution
Table Galmed International Information List
Table Type I Nonalcoholic Fatty Liver Disease Overview
Table Type II Nonalcoholic Fatty Liver Disease Overview
Table Type III Nonalcoholic Fatty Liver Disease Overview
Table 2015 Galmed International Nonalcoholic Fatty Liver Disease Revenue, Sales, Ex-factory Price
Figure 2015 Galmed International 2015 Nonalcoholic Fatty Liver Disease Business Region Distribution
Table Kyorin Pharmaceutical Information List
Table Type I Nonalcoholic Fatty Liver Disease Overview
Table Type II Nonalcoholic Fatty Liver Disease Overview
Table Type III Nonalcoholic Fatty Liver Disease Overview
Table 2015 Kyorin Pharmaceutical Nonalcoholic Fatty Liver Disease Revenue, Sales, Ex-factory Price
Figure 2015 Kyorin Pharmaceutical 2015 Nonalcoholic Fatty Liver Disease Business Region Distribution
Table Metabolic Solutions Development Information List
Table Type I Nonalcoholic Fatty Liver Disease Overview
Table Type II Nonalcoholic Fatty Liver Disease Overview
Table Type III Nonalcoholic Fatty Liver Disease Overview
Table 2015 Metabolic Solutions Development Nonalcoholic Fatty Liver Disease Revenue, Sales, Ex-factory Price
Figure 2015 Metabolic Solutions Development 2015 Nonalcoholic Fatty Liver Disease Business Region Distribution
Table Novartis AG Information List
Table Type I Nonalcoholic Fatty Liver Disease Overview
Table Type II Nonalcoholic Fatty Liver Disease Overview
Table Type III Nonalcoholic Fatty Liver Disease Overview
Table 2015 Novartis AG Nonalcoholic Fatty Liver Disease Revenue, Sales, Ex-factory Price
Figure 2015 Novartis AG 2015 Nonalcoholic Fatty Liver Disease Business Region Distribution
Table Phenex Pharmaceuticals Information List
Table Type I Nonalcoholic Fatty Liver Disease Overview
Table Type II Nonalcoholic Fatty Liver Disease Overview
Table Type III Nonalcoholic Fatty Liver Disease Overview
Table 2015 Phenex Pharmaceuticals Nonalcoholic Fatty Liver Disease Revenue, Sales, Ex-factory Price
Figure 2015 Phenex Pharmaceuticals 2015 Nonalcoholic Fatty Liver Disease Business Region Distribution
Table Raptor Pharmaceuticals Information List
Table Type I Nonalcoholic Fatty Liver Disease Overview
Table Type II Nonalcoholic Fatty Liver Disease Overview
Table Type III Nonalcoholic Fatty Liver Disease Overview
Table 2015 Raptor Pharmaceuticals Nonalcoholic Fatty Liver Disease Revenue, Sales, Ex-factory Price
Figure 2015 Raptor Pharmaceuticals 2015 Nonalcoholic Fatty Liver Disease Business Region Distribution
Table TCM Biotech International Information List
Table Type I Nonalcoholic Fatty Liver Disease Overview
Table Type II Nonalcoholic Fatty Liver Disease Overview
Table Type III Nonalcoholic Fatty Liver Disease Overview
Table 2015 TCM Biotech International Nonalcoholic Fatty Liver Disease Revenue, Sales, Ex-factory Price
Figure 2015 TCM Biotech International 2015 Nonalcoholic Fatty Liver Disease Business Region Distribution
Table Tobira Therapeutics Information List
Table Type I Nonalcoholic Fatty Liver Disease Overview
Table Type II Nonalcoholic Fatty Liver Disease Overview
Table Type III Nonalcoholic Fatty Liver Disease Overview
Table 2015 Tobira Therapeutics Nonalcoholic Fatty Liver Disease Revenue, Sales, Ex-factory Price
Figure 2015 Tobira Therapeutics 2015 Nonalcoholic Fatty Liver Disease Business Region Distribution
Figure Global 2016-2021 Nonalcoholic Fatty Liver Disease Market Size (Volume) and Growth Rate Forecast
Figure Global 2016-2021 Nonalcoholic Fatty Liver Disease Market Size (Value) and Growth Rate Forecast
Figure Global 2016-2021 Nonalcoholic Fatty Liver Disease Sales Price (USD/Unit) Forecast
Figure North America 2016-2021 Nonalcoholic Fatty Liver Disease Consumption Volume and Growth Rate Forecast
Figure China 2016-2021 Nonalcoholic Fatty Liver Disease Consumption Volume and Growth Rate Forecast
Figure Europe 2016-2021 Nonalcoholic Fatty Liver Disease Consumption Volume and Growth Rate Forecast
Figure Southeast Asia 2016-2021 Nonalcoholic Fatty Liver Disease Consumption Volume and Growth Rate Forecast
Figure Japan 2016-2021 Nonalcoholic Fatty Liver Disease Consumption Volume and Growth Rate Forecast
Figure India 2016-2021 Nonalcoholic Fatty Liver Disease Consumption Volume and Growth Rate Forecast
Table Global Sales Volume (K Units) of Nonalcoholic Fatty Liver Disease by Types 2016-2021
Table Global Consumption Volume (K Units) of Nonalcoholic Fatty Liver Disease by Applications 2016-2021
Table Traders or Distributors with Contact Information of Nonalcoholic Fatty Liver Disease by Regions
Table Part of Interviewees Record List
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
